NO173901C - Fremgangsmaate, monoklonalt antistoff og sett for maaling av vevplasminogenaktivator-aktivitet - Google Patents
Fremgangsmaate, monoklonalt antistoff og sett for maaling av vevplasminogenaktivator-aktivitetInfo
- Publication number
- NO173901C NO173901C NO883063A NO883063A NO173901C NO 173901 C NO173901 C NO 173901C NO 883063 A NO883063 A NO 883063A NO 883063 A NO883063 A NO 883063A NO 173901 C NO173901 C NO 173901C
- Authority
- NO
- Norway
- Prior art keywords
- kit
- procedure
- monoclonal antibody
- plasminogen activator
- tissue plasminogen
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
- C12Q2337/10—Anilides
- C12Q2337/12—Para-Nitroanilides p-NA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9726—Tissue plasminogen activator
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17230087 | 1987-07-10 | ||
JP17807387 | 1987-07-16 | ||
JP32800487 | 1987-12-23 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO883063D0 NO883063D0 (no) | 1988-07-08 |
NO883063L NO883063L (no) | 1989-01-11 |
NO173901B NO173901B (no) | 1993-11-08 |
NO173901C true NO173901C (no) | 1994-02-16 |
Family
ID=27323604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO883063A NO173901C (no) | 1987-07-10 | 1988-07-08 | Fremgangsmaate, monoklonalt antistoff og sett for maaling av vevplasminogenaktivator-aktivitet |
Country Status (10)
Country | Link |
---|---|
US (1) | US5102787A (ko) |
EP (1) | EP0298783B1 (ko) |
KR (1) | KR890002663A (ko) |
AU (1) | AU621823B2 (ko) |
CA (1) | CA1331158C (ko) |
DE (1) | DE3875826T2 (ko) |
DK (1) | DK381288A (ko) |
ES (1) | ES2035923T3 (ko) |
FI (1) | FI89634C (ko) |
NO (1) | NO173901C (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3722082A1 (de) * | 1987-07-03 | 1989-01-12 | Behringwerke Ag | Verfahren zur bestimmung der aktivitaet von serinproteasen oder serinproteaseinhibitoren |
EP0339302B1 (en) * | 1988-04-04 | 1993-12-22 | Teijin Limited | Reagent system for immunologically assaying complex of human plasminogen activator inhibitor and human tissue plasminogen activator, and assay kit therefor |
DE3911794A1 (de) * | 1989-04-11 | 1990-10-18 | Thomae Gmbh Dr K | Monoklonale antikoerper gegen rekombinaten humanen gewebeplasminogenaktivator mit definierter epitopspezifitaet, deren herstellung und deren verwendung |
SE9201615L (sv) * | 1992-05-21 | 1993-11-22 | Chromogenix Ab | Bioimmunologisk metod för bestämning av tPa och PAI-1 |
US6350571B1 (en) * | 1996-02-01 | 2002-02-26 | Vinata B. Lokeshwar | Methods for detection and evaluation of bladder cancer |
WO2000065349A2 (en) * | 1999-04-28 | 2000-11-02 | Cardiogenics Inc. | Method for determining plasminogen activator inhibitor |
EP2333555A1 (de) | 2009-12-09 | 2011-06-15 | Siemens Healthcare Diagnostics Products GmbH | Heterogener Gerinnungstest |
WO2014116706A1 (en) * | 2013-01-22 | 2014-07-31 | University Of Tennessee Research Foundation | Tissue plasminogen activator antibodies and methods of use thereof |
CN116068179B (zh) * | 2022-07-20 | 2024-03-19 | 华中科技大学同济医学院附属同济医院 | 一种用于检测人组织型纤溶酶原激活物的胶体金试纸条 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2952478A1 (de) * | 1979-12-27 | 1981-07-30 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren und mittel zur immunologischen bestimmung von enzymen |
GB2095400A (en) * | 1981-03-21 | 1982-09-29 | Self Colin Henry | Detection of enzyme using supported enzyme binder |
DE3222084A1 (de) * | 1982-06-11 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Monoklonale antikoerper |
AU572125B2 (en) * | 1983-03-17 | 1988-05-05 | Mabco Limited | Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses |
US4629694A (en) * | 1983-07-12 | 1986-12-16 | Cornell Research Foundation, Inc. | Detecting and distinguishing between plasminogen activators |
FR2561661B1 (fr) * | 1984-03-23 | 1987-02-06 | Inst Nat Sante Rech Med | Pellicule moleculaire supportee d'un reseau de fibrine permettant la retention selective, a sa surface, de l'activateur du plasminogene tissulaire et applications en decoulant |
EP0190711B1 (en) * | 1985-02-07 | 1989-04-26 | Kowa Company, Ltd. | Monoclonal antibodies to tissue plasminogen activator derived from human normal cells |
SE447579B (sv) * | 1985-04-01 | 1986-11-24 | Biopool Ab | Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar |
DE3512909A1 (de) * | 1985-04-11 | 1986-10-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur bestimmung von plasminogenaktivatoren (pa) |
DK319685A (da) * | 1985-07-12 | 1987-01-13 | Fonden Til Fremme Af Eksperime | Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne |
US4720455A (en) * | 1985-09-06 | 1988-01-19 | Pitman-Moore, Inc. | Progesterone assay method for mammals and monoclonal antibody therefor |
US4833085A (en) * | 1986-08-13 | 1989-05-23 | Monsanto Company | Monoclonal antibody specific for human colon fibroblast-derived t-PA |
-
1988
- 1988-07-05 FI FI883200A patent/FI89634C/fi not_active IP Right Cessation
- 1988-07-05 US US07/215,213 patent/US5102787A/en not_active Expired - Fee Related
- 1988-07-06 CA CA000571321A patent/CA1331158C/en not_active Expired - Fee Related
- 1988-07-08 DK DK381288A patent/DK381288A/da not_active Application Discontinuation
- 1988-07-08 NO NO883063A patent/NO173901C/no unknown
- 1988-07-09 KR KR1019880008567A patent/KR890002663A/ko not_active Application Discontinuation
- 1988-07-11 EP EP88306314A patent/EP0298783B1/en not_active Expired - Lifetime
- 1988-07-11 ES ES198888306314T patent/ES2035923T3/es not_active Expired - Lifetime
- 1988-07-11 AU AU18927/88A patent/AU621823B2/en not_active Ceased
- 1988-07-11 DE DE8888306314T patent/DE3875826T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI89634C (fi) | 1993-10-25 |
AU621823B2 (en) | 1992-03-26 |
CA1331158C (en) | 1994-08-02 |
AU1892788A (en) | 1989-02-09 |
DK381288A (da) | 1989-02-17 |
ES2035923T3 (es) | 1993-05-01 |
FI883200A (fi) | 1989-01-11 |
DE3875826T2 (de) | 1993-05-27 |
DE3875826D1 (de) | 1992-12-17 |
FI89634B (fi) | 1993-07-15 |
NO883063L (no) | 1989-01-11 |
EP0298783A1 (en) | 1989-01-11 |
DK381288D0 (da) | 1988-07-08 |
FI883200A0 (fi) | 1988-07-05 |
KR890002663A (ko) | 1989-04-11 |
US5102787A (en) | 1992-04-07 |
NO173901B (no) | 1993-11-08 |
NO883063D0 (no) | 1988-07-08 |
EP0298783B1 (en) | 1992-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK101890A (da) | Monoklonale antistoffer mod human interleukin-4 og hybridomaer, der producerer saadanne | |
NO864473L (no) | Perlemorskimrende sjampo og fremgangsmaate for fremstilling av denne. | |
DK96787A (da) | Human vaevs-plasminogenaktivator | |
FR2631239B1 (fr) | Anticorps monoclonal humain et hybridome le produisant | |
NO173901C (no) | Fremgangsmaate, monoklonalt antistoff og sett for maaling av vevplasminogenaktivator-aktivitet | |
DE3689948D1 (de) | Monoklonale antikörper und testverfahren. | |
NO893892D0 (no) | Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse. | |
DK166489D0 (da) | Monoklonale antistoffer mod vaevsplasminogen-aktivator (t-pa), deres fremstilling og anvendelse | |
DK717888D0 (da) | Monoklonale antistoffer | |
FI883943A0 (fi) | Modifierade plasminogen-aktivatorer. | |
DK392288D0 (da) | Human monoklonale antistoffer samt profylaktiske ohuman monoklonale antistoffer samt profulaktiske og terapeutiske midler mod infrektioese sygdomme,deg terapeutiske midler mod infrektioese sygdomme, dr indeholder samme som aktiv bestanddel er indeholder samme som aktiv bestanddel | |
NO168055C (no) | Fremgangsmaate for fremstilling av human vevplasminogenaktivator og urokinase-type plasminogenaktivator. | |
DE68911574D1 (de) | Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür. | |
NO802095L (no) | Fremgangsmaate og reagenser for blodtypebestemmelse | |
DK270386D0 (da) | Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse | |
DK8089A (da) | Monoclonale antistoffer, deres fremstilling og anvendelse. | |
NO891756D0 (no) | Teststrimler for bestemmelse av urinstoff og deres anvendelse. | |
DK370089A (da) | Anti-urokinase monoklonale antistoffer | |
FI91777B (fi) | Menetelmä plasmiiniaktiivisuuden määrittämiseksi | |
DK37489D0 (da) | Proteiner afledt af human alpha2-plasmininhibitor og dermed beslaegtede proteiner | |
DK307189D0 (da) | Fremgangsmaade til kvantitativ bestemmelse | |
IE891354L (en) | Monoclonal antibodies to tissue plasminogen activator | |
NO872633L (no) | Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav. | |
NO894369L (no) | Fremgangsmaate for bestemmelse av aktivitet av antithrombin iii og reagensmiddel for anvendelse derved. | |
NO955220L (no) | Anvendelse av antistoff for påvisning av human plasminogenaktivatorinhibitor |